Eicos Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Eicos Sciences’ Aurlumyn is the first FDA-approved treatment for the prevention of amputation caused by severe frostbite.

The Food and Drug Administration this month approved the first ever medication to treat severe frostbite in adults, a move that could reduce the risk...

Frostbite may have met its match. The U.S. Food and Drug Administration (FDA) has approved the first medication to treat severe frostbite, the agency announced this week. The drug, iloprost (brand name Aurlumyn) is intended to reduce the risk of finger and toe amputations due to dangerously cold extremities. NEED A 'WINTER RESET'? EXPERTS SHARE

WASHINGTON, DC, February 15, 2024 (ENS) - The U.S. Food and Drug Administration has approved a new drug - an injection to treat severe frostbite in adults that reduces the risk of finger or toe, nose or ear amputation. The iloprost injection, marketed under the brand name Aurlumyn, is a vasodilator, a drug that opens blood vessels and prevents blood clotting. %environment_news_service% news environment latest on forests, oceans, climate, wildlife, fisheries, transportation, business

The U.S. Food and Drug Administration (FDA) approved the first medication to treat severe frostbite, the agency announced this week. Dr. Marc Siegel, Fox News medical contributor, weighed in.